Michael W. Kalb

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Dix Hills, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael W. Kalb
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael W. Kalb

Form 4 holding Executive Vice President & CFO

CATALYST PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
632,903
Estimated value
$1,907,553
Report date
05 Jan 2026
Price
$4.01
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP and CFO

AMARIN CORP PLC\UK

Security class
Ordinary Shares
Shares / value
337,314
Estimated value
$367,672
Report date
01 Aug 2022
Price
$1.09
Ownership
Direct
Form 4 holding CFO

IMPEL PHARMACEUTICALS INC

Security class
Stock Option (right to buy)
Shares / value
175,000
Estimated value
Report date
10 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP and CFO

AMARIN CORP PLC\UK

Security class
Restricted Stock Units
Shares / value
95,533
Estimated value
Report date
29 Jul 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding CFO

IMPEL PHARMACEUTICALS INC

Security class
Restricted Stock Units (RSUs)
Shares / value
47,500
Estimated value
Report date
10 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP & Chief Financial Officer

CinCor Pharma, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Feb 2023
Price
$28.75
Ownership
Direct
Form 4 holding EVP & Chief Financial Officer

CinCor Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
24 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael W. Kalb

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .